Bayer to Expand Partnership with M2i Group
July 15, 2025 
Photo: MPrise Software
Bayer, a German pharmaceutical and biotechnology company, signed a development and distribution agreement with French pheromones company M2i Group for the exclusive distribution of pheromone gels for the Asia-Pacific as well as the Latin America region and the U.S. on July 14. This builds on the company’s successful collaboration and related product launches in Europe and Africa.
Through an agreement signed in 2023 with M2i Group, Bayer has become the exclusive distributor of selected M2i products in Europe and some African countries targeting lepidoptera and some sucking pests in crops that include stone and pome fruits, tomatoes, and grapes. Now, the two companies expand their scope to serve farmers beyond Europe and Africa and strengthen their strategic partnership to deliver biological crop protection solutions on a global scale.
Strategic partnerships in the biologicals space are key for Bayer and a crucial part of the company’s open innovation approach: combining leading Research & Development capabilities with knowledge and ingenuity from experts outside the company.
M2i Group is a leader in pheromone production in Europe and has expertise in developing, formulating, and manufacturing complex molecules. By kicking off the partnership in 2023, Bayer has started to integrate M2i’s pheromone products, including M2i’s innovative press application technology, into a complementary system of digitally enabled solutions that include pest monitoring tools to advise growers on pest pressures and application timelines, and other synthetic and biological products tailored to grower needs.
